Riedel Norbert G

DirectorJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Mar 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$656K
Net Open-Market Flow
-$656K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 27, 2026Option exercise(M)3K$138.08$472K10K
Feb 27, 2026Sell(S)3K$192.00$656K7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 27, 2026Option exercise(M)3K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001161662-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: